Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net earnings (loss)	$ (11,827)	$ 124
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation and amortization	20,383	20,749
Amortization of premium/discount on marketable securities	(1,074)	1,894
Change in fair value of contingent consideration	7,660	(1,095)
Share-based compensation expense	8,068	5,897
Deferred income tax benefit	(3,990)	(5,482)
Inventory valuation write-down	547	730
Payment of contingent consideration	(4,900)	0
Other noncash adjustments, net	1,826	1,719
Changes in operating assets and liabilities:
Accounts receivable	(3,563)	(3,579)
Inventories	4,731	1,990
Prepaid expenses and other assets	7,372	(7,517)
Accrued product returns and rebates	1,428	12,952
Accounts payable and other liabilities	3,938	10,019
Net cash provided by operating activities	30,599	38,401
Cash flows from investing activities
Purchases of marketable securities	(118,557)	(193,700)
Maturities of marketable securities	156,201	142,324
Purchases of property and equipment	(327)	(248)
Net cash provided by (used in) investing activities	37,317	(51,624)
Cash flows from financing activities
Proceeds from issuance of common stock	2,042	2,910
Employee taxes paid related to net share settlement of equity awards	(3,341)	(1,340)
Payment of contingent consideration	(20,100)	0
Net cash provided by (used in) financing activities	(21,399)	1,570
Net change in cash and cash equivalents	46,517	(11,653)
Cash and cash equivalents at beginning of year	69,331	75,054
Cash and cash equivalents at end of period	115,848	63,401
Supplemental cash flow information
Cash paid for income taxes	274	336
Cash paid for operating leases	3,892	4,002
Noncash investing and financing activities
Lease assets obtained for new operating leases	$ 0	$ 2,604